Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Varenicline Attenuates Some of the Subjective and Physiological Effects of Intravenous Nicotine in Humans.

NCT00606892 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT00606892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00606892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Varenicline Attenuates Some of the Subjective and Physiological Effects of Intravenous Nicotine in Humans.
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2007
Completion date
November 30, 2009
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation